Alyssa Bilinski
Overview
Explore the profile of Alyssa Bilinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
665
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Lin E, Bilinski A, Collender P, Lee V, Sud S, Leon T, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2444836.
PMID: 39541118
Importance: Understanding the role of school attendance on transmission of SARS-CoV-2 among children is of importance for responding to future epidemics. Estimating discontinuities in outcomes by age of eligibility for...
4.
Fortnam T, Chambers L, Bilinski A, DeVito R, Gargano L, Wilson M, et al.
Am J Public Health
. 2024 Aug;
114(S7):S580-S589.
PMID: 39197141
To determine whether geographic prioritization of limited COVID-19 vaccine supply was effective for reducing geographic disparities in case rates. Rhode Island allocated a portion of the initial COVID-19 vaccine supply...
5.
Bilinski A, Ganguli I
JAMA Intern Med
. 2024 Aug;
184(10):1161-1162.
PMID: 39186291
No abstract available.
6.
Dong S, Jutkowitz E, Giardina J, Bilinski A
JAMA Health Forum
. 2024 Apr;
5(4):e240688.
PMID: 38669030
Importance: Nursing home residents continue to bear a disproportionate share of COVID-19 morbidity and mortality, accounting for 9% of all US COVID-19 deaths in 2023, despite comprising only 0.4% of...
7.
Bilinski A, Slimovitch R, Mendlowitz A, Feld J, Salomon J
Clin Infect Dis
. 2023 Aug;
77(Suppl 3):S231-S237.
PMID: 37579207
Background: In 2019, about 58 million individuals were chronically infected with hepatitis C virus. Some experts have proposed challenge trials for hepatitis C virus vaccine development. Methods: We modeled incremental...
8.
Nelson S, Dugdale C, Brenner I, Crawford A, Bilinski A, Cosar D, et al.
JAMA Health Forum
. 2023 Aug;
4(8):e232310.
PMID: 37540523
Importance: School-associated SARS-CoV-2 transmission is described as uncommon, although the true transmission rate is unknown. Objective: To identify the SARS-CoV-2 secondary attack rate (SAR) in schools and factors associated with...
9.
Khunte M, Kumar S, Salomon J, Bilinski A
JAMA Health Forum
. 2023 Mar;
4(3):e230046.
PMID: 36930169
No abstract available.
10.
Chitwood M, Kwon J, Savinkina A, Walker J, Bilinski A, Gonsalves G
JAMA Netw Open
. 2023 Jan;
6(1):e2250984.
PMID: 36637825
No abstract available.